Evolution of HIV and HCV coinfected children receiving long-term lopinavir/ritonavir-based antiretroviral therapy

被引：0
|
作者：
Larru, Beatriz [1 ]
Resino, Salvador [1 ,2 ]
Bellon, Jose M. [1 ]
Isabel de Jose Gomez, M. [3 ]
Fortuna, Claudia [4 ]
Munoz-Fernandez, M. Angeles [1 ]
机构：
[1] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid 28007, Spain
[2] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain
[3] Hosp Univ La Paz, Serv Inmunopediat, Madrid, Spain
[4] Hosp San Joan de Deu, Serv Inmunopediat, Barcelona, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2008年 / 26卷 / 07期
关键词：
HIV; HCV; LPV/r; HAART; children;
D O I：
10.1157/13125640
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
INTRODUCTION. There are few studies investigating the effect of HCV coinfection on HIV-related disease among children. METHODS. We studied 5 HIV/HCV coinfected children receiving an LPV/r-containing HAART regimen. Their evolution was compared with a control group of 72 HIV-infected children. RESULTS. All 5 HIV/HCV-coinfected children achieved sustained immune recovery during the study. Moreover, they showed better viral suppression than the control group. None of the 5 HIV/HCV-coinfected children experienced any adverse effects with the use of LPV/r. CONCLUSION. HIV/HCV coinfection does not reduce the benefits obtained from HAART.
引用
收藏
页码：426 / 429
页数：4
相关论文
共 50 条
  • [21] Lack of HCV transmission from HCV and HIV coinfected mothers on antiretroviral therapy to children
    Minola, E
    Colucci, A
    Fracassetti, O
    Fraquelli, M
    Suter, F
    Prati, D
    Conte, D
    JOURNAL OF HEPATOLOGY, 2001, 34 : 3 - 4
  • [22] Long-term safety and effectiveness of ritonavir (RTV), nelfinavir (NFV) and lopinavir/ritonavir (LPWr) in antiretroviral (ARV)-experienced HIV-1-infected children
    Rudin, Christoph
    Burri, Marcus
    Shen, Yang
    Rode, Richard
    Nadal, David
    SWISS MEDICAL WEEKLY, 2007, 137 : 13S - 13S
  • [23] HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%
    Shuter, Jonathan
    Sarlo, Julie A.
    Kanmaz, Tina J.
    Rode, Richard A.
    Zingman, Barry S.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) : 4 - 8
  • [24] Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV-infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy
    Naiker, Suhashni
    Connolly, Cathy
    Wiesner, Lubbe
    Kellerman, Tracey
    Reddy, Tarylee
    Harries, Anthony
    McIlleron, Helen
    Lienhardt, Christian
    Pym, Alexander
    BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15
  • [25] Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy
    Suhashni Naiker
    Cathy Connolly
    Lubbe Wiesner
    Tracey Kellerman
    Tarylee Reddy
    Anthony Harries
    Helen McIlleron
    Christian Lienhardt
    Alexander Pym
    BMC Pharmacology and Toxicology, 15
  • [26] ASSOCIATION BETWEEN LIPODYSTROPHY AND LEPTIN IN HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED CHILDREN RECEIVING LOPINAVIR/RITONAVIR-BASED THERAPY
    Resino, Salvador
    Palladino, Claudia
    Lorente, Raquel
    Micheloud, Dariela
    Maria Bellon, Jose
    Larru, Beatriz
    Gurbindo Gutierrez, Maria Dolores
    Isabel de Jose, Maria
    Polo, Rosa
    Angeles Munoz-Fernandez, Maria
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (08) : 774 - 777
  • [27] Lopinavir/ritonavir-based Second Line Antiretroviral Treatment in children at National Pediatric Hospital, Phnom Penh, Cambodia
    Sam, S.
    Ung, V.
    Huot, C.
    Courpotin, C.
    Nerrienet, Eric
    Pugatch, David
    Mayer, Kenneth
    Chhour, Y. M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 157 - 157
  • [28] Lopinavir/ritonavir-based second line antiretroviral treatment in children at National Pediatric Hospital, Phnom Penh, Cambodia
    Sophan Sam
    Vibol Ung
    Chantheany Huot
    Bunnthy Chan
    Kdan Yuvatha
    Christian Courpotin
    Guillaume Adam
    Sopheak Ngin
    Eric Nerrienet
    Y Meng Chhour
    Retrovirology, 6 (Suppl 1)
  • [29] Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir
    Martínez, E
    Domingo, P
    Galindo, MJ
    Milinkovic, A
    Arroyo, JA
    Baldoví, F
    Larrousse, M
    León, A
    de Lazzari, E
    Gatell, JM
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (07) : 1017 - 1023
  • [30] Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy
    Verucchi, G
    Calza, L
    Biagetti, C
    Attard, L
    Costigliola, P
    Manfredi, R
    Pasquinelli, G
    Chiodo, F
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (03) : 326 - 328
12345